Airway Obstruction Articles & Analysis
15 news found
Obesity is a metabolic condition resulting from an imbalance between the energy consumed and the energy expended. This is often caused by an increase in the intake of calorie-dense foods and a decrease in physical activity, leading to an abnormal build-up of fat. Such fat accumulation can have serious health consequences, raising the risk of chronic diseases like cardiovascular conditions, ...
About Atectura® Breezhaler® Atectura® Breezhaler® is indicated as a once-daily maintenance treatment of asthma in adults and adolescents 12 years of age and older with reversible obstructive airways disease. Atectura® Breezhaler® should be prescribed for patients not adequately controlled on a long-term asthma control medication, such as ...
About Atectura® Breezhaler® Atectura® Breezhaler® is indicated as a once-daily maintenance treatment of asthma in adults and adolescents 12 years of age and older with reversible obstructive airways disease. Atectura® Breezhaler® should be prescribed for patients not adequately controlled on a long-term asthma control medication, such ...
Termed the SUPRA study (Study Using Negative Pressure to Reduce Apnea), the trial will evaluate the treatment benefits and safety of applying mild external vacuum over the upper airway with the aerSleep® II device in subjects with moderate and severe OSA who are unable to use standard therapy with continuous positive airway pressure (CPAP) provided by ...
The role of spirometry in diagnosing and monitoring chronic obstructive airway diseases is crucial. According to WHO, the demonstration of irreversible airway obstruction is essential for diagnosing chronic obstructive pulmonary disease (COPD), which is the third leading cause of death worldwide. ...
ByAioCare
Aerin Medical Aerin Medical has developed the VivAer and RhinAer platform technologies to treat patients suffering from nasal airway obstruction, and chronic rhinitis, respectively. Two-year results from Aerin Medical’s multi-center, prospective study were recently published in the International Forum of Allergy and Rhinology. The study found that 97.2% of ...
The Study Using negative Pressure to Reduce Apnea (SUPRA) clinical trial will evaluate the safety and effectiveness of the aerSleep II device for treatment of moderate to severe Obstructive Sleep Apnea (OSA) over 24 weeks of home use in subjects who are intolerant of Continuous Positive Airway Pressure (CPAP) therapy. ...
” aerSleep II applies negative pressure over the external surface of the neck to hold the airway open during sleep. It is a self-contained unit with an integral vacuum pump which is quiet, and easy to use and maintain. ...
Since the modified aerSleep® product is external to the airway, its use does not pose a risk of creating infectious aerosols, like some types of non-invasive ventilation such as Continuous Positive Airway Pressure (CPAP). ...
— JUNE 25, 2019 — Sommetrics a company dedicated to developing state of the art products to treat obstructive sleep apnea (OSA), today announced the completion of clinical study SOM-014. ...
This Summit is a yearly event held in advance of the American Thoracic Society’s International meeting which brings together clinicians, innovators and investors focused on new approaches for treating widespread and crippling lung and airway diseases. “This is an ideal venue for highlighting the clinical progress made in establishing our aerSleep™ system as a ...
” Continuous negative external pressure (cNEP®), now referred to as aer+ technology, is Sommetrics’ patented technology that uses the application of negative external air pressure on the outside of the neck to gently hold the airway open. This innovative technology is integrated into aerSleepTM, the company’s non-invasive solution to treat ...
This capital will support the company’s development and commercialization of products to treat disorders of the upper airway such as obstructive sleep apnea and chronic snoring. “Our mission is to improve the quality of sleep for people worldwide,” said Richard Rose, M.D., Sommetrics’ CEO and board chair. ...
“There are a great number of underlying mechanisms that can trigger a cardiac arrest, such as an airway obstruction, a metabolic imbalance, a drug overdose, a critical bleeding, a collapsed lung,” says Frost. ...
” After inhaling house dust, mice that were able to respond to flagellin displayed all of the common symptoms of allergic asthma, including more mucous production, airway obstruction, and airway inflammation. However, mice lacking a gene that detects the presence of flagellin had reduced levels of these symptoms. ...